AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30839430 — intervention group
Group type: COMPARATOR
Intervention: Loxoprofen tablet (LX-T)
Number of subjects: 242
Study 28679073 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Carers Medicines Management (CCMM)
Number of subjects: 57
Study 28679073 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-delivered structured conversational process
Number of subjects: 57
Study 26551528 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 115
Study 26551528 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower oil
Number of subjects: 115
Study 26551528 — intervention group
Group type: COMPARATOR
Intervention: No oil
Number of subjects: 115
Study 25211703 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (150 mg)
Number of subjects: 16
Study 25211703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22356705 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of neutral 0.025% sodium fluoride rinse (group II)
Number of subjects: 80
Study 22356705 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth mousse twice a day in addition to fluoride toothpaste for 6 months (group III)
Number of subjects: 80
Study 22356705 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion technique (group IV)
Number of subjects: 80
Study 22356705 — intervention group
Group type: COMPARATOR
Intervention: Brushing teeth only (control group I)
Number of subjects: 80
Study 19652851 — intervention group
Group type: EXPERIMENTAL
Intervention: External Fixation (EF)
Number of subjects: 35
Study 19652851 — intervention group
Group type: COMPARATOR
Intervention: Open Reduction Internal Fixation (ORIF) with plates and screws
Number of subjects: 35
Study 17080442 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP) 0.25 mg/kg
Number of subjects: 7
Study 15219473 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 21
Study 11829722 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage antiretroviral therapy (specific agents not detailed)
Number of subjects: 0
Study 11829722 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance testing and pharmacokinetic interactions
Number of subjects: 0
Study 11829722 — intervention group
Group type: EXPERIMENTAL
Intervention: New agents and new classes of drugs in salvage therapy
Number of subjects: 0
Study 9810992 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone occlusive sheeting (Sil-K) used in 68 patients
Number of subjects: 129
Study 9810992 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone occlusive gel (Epiderm) used in 61 patients
Number of subjects: 129
Study 9810992 — intervention group
Group type: COMPARATOR
Intervention: Micropore (control group)
Number of subjects: 129
Study 7653448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin/Niacin
Number of subjects: 65
Study 7653448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin/Magnesium
Number of subjects: 65
Study 7653448 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin/Placebo
Number of subjects: 65
Study 2648927 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (32 mg)
Number of subjects: 66
Study 2648927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 1103271 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenoxylate 5 mg three times daily
Number of subjects: 20
Study 1103271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30738047 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 499
Study 27887804 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 70
Study 27887804 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM + Physiotherapy (PT)
Number of subjects: 70
Study 27887804 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 70
Study 25257157 — intervention group
Group type: EXPERIMENTAL
Intervention: Stronger Kurdish identity
Number of subjects: 0
Study 25257157 — intervention group
Group type: EXPERIMENTAL
Intervention: Stronger common ingroup identity
Number of subjects: 0
Study 25257157 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural disadvantage
Number of subjects: 0
Study 24552358 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine 8 mg
Number of subjects: 1955
Study 24552358 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine 4 mg
Number of subjects: 1955
Study 24552358 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1955
Study 21609340 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing (DDD)
Number of subjects: 19
Study 21609340 — intervention group
Group type: COMPARATOR
Intervention: Atrial synchronous pacing (VDD)
Number of subjects: 19
Study 18551007 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term repeatability of morning blood pressure measurements
Number of subjects: 173
Study 18551007 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term repeatability of morning blood pressure measurements
Number of subjects: 173
Study 18551007 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorical analysis of short-term repeatability of morning surge
Number of subjects: 173
Study 18551007 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorical analysis of long-term repeatability of morning surge
Number of subjects: 173
Study 16522387 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry + cardiotocograph monitoring
Number of subjects: 600
Study 16522387 — intervention group
Group type: COMPARATOR
Intervention: Cardiotocograph-only monitoring
Number of subjects: 600
Study 14527904 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium chemoprevention
Number of subjects: 220
Study 14527904 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 220
Study 11228945 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Body Weight-Supported Treadmill Training (PBWSTT)
Number of subjects: 56
Study 11228945 — intervention group
Group type: COMPARATOR
Intervention: Aggressive Bracing Assisted Walking (ABAW)
Number of subjects: 56
Study 8838189 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (ABLC) at 1.2-5.0 mg/(kg.d) for 6 weeks
Number of subjects: 55
Study 8838189 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (AmB) at 0.7-1.2 mg/(kg.d) for 6 weeks
Number of subjects: 55
Study 8838189 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (ABLC)
Number of subjects: 55
Study 8838189 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (AmB)
Number of subjects: 55
Study 1457695 — intervention group
Group type: COMPARATOR
Intervention: Low flux hemodialysis (cuprophane)
Number of subjects: 32
Study 1457695 — intervention group
Group type: COMPARATOR
Intervention: High flux hemodialysis (polysulfone)
Number of subjects: 32
Study 1457695 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemofiltration (high flux polysulfone)
Number of subjects: 32
Study 6656341 — intervention group
Group type: EXPERIMENTAL
Intervention: On-service housestaff
Number of subjects: 0
Study 6656341 — intervention group
Group type: COMPARATOR
Intervention: Off-service housestaff
Number of subjects: 0
Study 30853454 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach (AA)
Number of subjects: 100
Study 30853454 — intervention group
Group type: COMPARATOR
Intervention: Posterior approach (PA)
Number of subjects: 100
Study 30853454 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 100
Study 28523988 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial therapy (8 sessions from 2 to 4 months post-surgery)
Number of subjects: 147
Study 28523988 — intervention group
Group type: COMPARATOR
Intervention: Standard physical therapy programme
Number of subjects: 147
Study 26502183 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental counseling to increase children's physical activity (n = 46)
Number of subjects: 91
Study 26502183 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 45)
Number of subjects: 91
Study 24290656 — intervention group
Group type: EXPERIMENTAL
Intervention: BM‐MNC+HOT
Number of subjects: 80
Study 24290656 — intervention group
Group type: EXPERIMENTAL
Intervention: BM‐MNC
Number of subjects: 80
Study 24290656 — intervention group
Group type: COMPARATOR
Intervention: HOT
Number of subjects: 80
Study 24290656 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 22965592 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient low-vision rehabilitation
Number of subjects: 100
Study 22965592 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 100
Study 19417018 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel with bevacizumab (DB)
Number of subjects: 49
Study 19417018 — intervention group
Group type: COMPARATOR
Intervention: docetaxel (D)
Number of subjects: 49
Study 17462117 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 24
Study 17462117 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 24
Study 15899921 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental education programme
Number of subjects: 284
Study 15899921 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support intervention
Number of subjects: 284
Study 15899921 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 284
Study 12645187 — intervention group
Group type: EXPERIMENTAL
Intervention: Low flow supplemental oxygen therapy
Number of subjects: 26
Study 9594864 — intervention group
Group type: EXPERIMENTAL
Intervention: SMA group (n = 10) - CPB circuit treated with surface-modifying additive (SMA)
Number of subjects: 20
Study 9594864 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10) - CPB circuit without treatment
Number of subjects: 20
Study 9594864 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 7542804 — intervention group
Group type: EXPERIMENTAL
Intervention: AZT-3TC combination therapy
Number of subjects: 0
Study 7542804 — intervention group
Group type: COMPARATOR
Intervention: AZT alone
Number of subjects: 0
Study 2466351 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolemic hemodilution (HH) with pentastarch
Number of subjects: 88
Study 2466351 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (S)
Number of subjects: 88
Study 80528 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin and gentamicin (C.G.)
Number of subjects: 90
Study 80528 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin and tobramycin (C.T.)
Number of subjects: 90
Study 80528 — intervention group
Group type: COMPARATOR
Intervention: Methicillin and gentamicin (M.G.)
Number of subjects: 90
Study 80528 — intervention group
Group type: COMPARATOR
Intervention: Methicillin and tobramycin (M.T.)
Number of subjects: 90
Study 80528 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cephalothin groups (C.G. and C.T.)
Number of subjects: 90
Study 80528 — intervention group
Group type: COMPARATOR
Intervention: Combined methicillin groups (M.G. and M.T.)
Number of subjects: 90
Study 31345981 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture-specific, barbershop-based intervention targeting masculinity barriers to care and CRC-screening uptake.
Number of subjects: 0
Study 31345981 — intervention group
Group type: EXPERIMENTAL
Intervention: Masculinity Barriers to Care Scale (MBCS) administered as an online quantitative survey.
Number of subjects: 0
Study 28678383 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg every 2 weeks)
Number of subjects: 122
Study 28678383 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab plus carboplatin
Number of subjects: 122
Study 26243685 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoteleconferencing (VTC)
Number of subjects: 126
Study 26243685 — intervention group
Group type: COMPARATOR
Intervention: In-person (NP)
Number of subjects: 126
Study 26243685 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions pooled together
Number of subjects: 126
Study 26243685 — intervention group
Group type: EXPERIMENTAL
Intervention: Veterans (VTC and NP combined)
Number of subjects: 126
Study 26243685 — intervention group
Group type: EXPERIMENTAL
Intervention: Civilians (VTC and NP combined)
Number of subjects: 126
Study 23883616 — intervention group
Group type: EXPERIMENTAL
Intervention: Unitcheck (Web-based personalized feedback intervention)
Number of subjects: 1478
Study 23883616 — intervention group
Group type: COMPARATOR
Intervention: Control (assessment only)
Number of subjects: 1478
Study 21277394 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (0.25 mg twice daily)
Number of subjects: 28
Study 21277394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 21277394 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 28
Study 19799571 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) system with varying call schedules (weekly, biweekly, monthly)
Number of subjects: 95
Study 19799571 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR system
Number of subjects: 95
Study 17433399 — intervention group
Group type: EXPERIMENTAL
Intervention: Preview condition
Number of subjects: 0
Study 17433399 — intervention group
Group type: COMPARATOR
Intervention: Full-set baseline
Number of subjects: 0
Study 17433399 — intervention group
Group type: EXPERIMENTAL
Intervention: Old distractor group differing in orientation from new distractors
Number of subjects: 0
Study 15696287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of dilute lidocaine (40 mg in 6.0 ml, 3.0 ml for each side or 4.0 and 2.0 ml for two sides)
Number of subjects: 46
Study 15696287 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (6.0 ml) as a placebo
Number of subjects: 46
Study 12475460 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen (CEE), 0.625 mg
Number of subjects: 38
Study 12475460 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol, 0.1 mg/day
Number of subjects: 38
Study 12475460 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 38
Study 12475460 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral CEE
Number of subjects: 38
Study 9808096 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydropyridine calcium channel blockers (CCB)
Number of subjects: 117
Study 9808096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 9808096 — intervention group
Group type: COMPARATOR
Intervention: ACEI
Number of subjects: 117
Study 9808096 — intervention group
Group type: EXPERIMENTAL
Intervention: CCB with ACEI
Number of subjects: 117
Study 9808096 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study population
Number of subjects: 117
Study 9808096 — intervention group
Group type: COMPARATOR
Intervention: CCB and placebo
Number of subjects: 117
Study 7711819 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental intervention
Number of subjects: 0
Study 2618921 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Instructional Parent Program (SIPP)
Number of subjects: 50
Study 2618921 — intervention group
Group type: COMPARATOR
Intervention: No program (Control group)
Number of subjects: 50
Study 722270 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Practice Group
Number of subjects: 240
Study 722270 — intervention group
Group type: COMPARATOR
Intervention: Family Planning Clinics Group
Number of subjects: 240
Study 31377901 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillotomy (ATT)
Number of subjects: 79
Study 31377901 — intervention group
Group type: COMPARATOR
Intervention: Adenotonsillectomy (ATE)
Number of subjects: 79
Study 28910185 — intervention group
Group type: EXPERIMENTAL
Intervention: Art therapy intervention for smoking cessation over six weeks.
Number of subjects: 66
Study 28910185 — intervention group
Group type: COMPARATOR
Intervention: Typical courses on smoking cessation (comparison group).
Number of subjects: 66
Study 26836732 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory central airway collapse (ECAC)
Number of subjects: 8820
Study 25347451 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (24 U)
Number of subjects: 445
Study 25347451 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 445
Study 23173246 — intervention group
Group type: EXPERIMENTAL
Intervention: bushui roumu recipe (BRR) combined with medroxyprogesterone acetate tablet (MAT)
Number of subjects: 90
Study 23173246 — intervention group
Group type: COMPARATOR
Intervention: bushui roumu recipe (BRR)
Number of subjects: 90
Study 23173246 — intervention group
Group type: COMPARATOR
Intervention: artificial period method (Western medicine group)
Number of subjects: 90
Study 23173246 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 20819495 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-assisted biopsy (VAB)
Number of subjects: 97
Study 20819495 — intervention group
Group type: COMPARATOR
Intervention: Wire localization (WL)
Number of subjects: 97
Study 17934163 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating, three-hole catheter (S3)
Number of subjects: 60
Study 17934163 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-stimulating three-hole catheter (NS3)
Number of subjects: 60
Study 17934163 — intervention group
Group type: COMPARATOR
Intervention: Stimulating, open-ended hole catheter (S1)
Number of subjects: 60
Study 17934163 — intervention group
Group type: EXPERIMENTAL
Intervention: All catheter types
Number of subjects: 60
Study 15975301 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebixiao granules (RBXG)
Number of subjects: 90
Study 15975301 — intervention group
Group type: COMPARATOR
Intervention: Futalin tablets (diclofenac sodium)
Number of subjects: 90
Study 12474115 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR (150 mg, PO)
Number of subjects: 20
Study 12474115 — intervention group
Group type: COMPARATOR
Intervention: Placebo (baseline sleep)
Number of subjects: 20
Study 15512257 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TVS)
Number of subjects: 130
Study 15512257 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal ultrasound (TAS)
Number of subjects: 130
Study 15512257 — intervention group
Group type: COMPARATOR
Intervention: Control group (not released results)
Number of subjects: 130
Study 7751433 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg daily
Number of subjects: 13
Study 7751433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 1969172 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam (3 mg, two daily doses)
Number of subjects: 245
Study 1969172 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorprothixene (15 mg, two daily doses)
Number of subjects: 245
Study 1969172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 351848 — intervention group
Group type: EXPERIMENTAL
Intervention: Active aerosol (betamethasone valerate, 800 microgram/day)
Number of subjects: 36
Study 351848 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone or prednisolone (30 mg/day)
Number of subjects: 36
Study 351848 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol
Number of subjects: 36
Study 30715214 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-1908-5p
Number of subjects: 710
Study 30715214 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-10b-5p
Number of subjects: 710
Study 30715214 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher plasma level of miR-199a
Number of subjects: 710
Study 30715214 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-143-3p and miR-145-5p
Number of subjects: 710
Study 27898343 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver gaze condition
Number of subjects: 49
Study 27898343 — intervention group
Group type: COMPARATOR
Intervention: Stranger gaze condition
Number of subjects: 49
Study 26123789 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lipid tolerance test (OLTT)
Number of subjects: 214
Study 26123789 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic fitness level
Number of subjects: 214
Study 24435725 — intervention group
Group type: COMPARATOR
Intervention: Standard restraints
Number of subjects: 20
Study 24435725 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversible pre-tensioned restraints
Number of subjects: 20
Study 24435725 — intervention group
Group type: COMPARATOR
Intervention: Normal driving
Number of subjects: 20
Study 24435725 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady state braking
Number of subjects: 20
Study 21866656 — intervention group
Group type: EXPERIMENTAL
Intervention: Quyu Jiedu Recipe (QYJDR) after laparoscopic surgery for 12 months
Number of subjects: 130
Study 21866656 — intervention group
Group type: COMPARATOR
Intervention: Routine progesterone treatment after laparoscopic surgery
Number of subjects: 130
Study 21866656 — intervention group
Group type: EXPERIMENTAL
Intervention: Quyu Jiedu Recipe (QYJDR) after laparoscopic surgery
Number of subjects: 130
Study 19196362 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 680
Study 19196362 — intervention group
Group type: EXPERIMENTAL
Intervention: General health perception
Number of subjects: 680
Study 19196362 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping strategies
Number of subjects: 680
Study 19196362 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported AEs
Number of subjects: 680
Study 19196362 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple drugs
Number of subjects: 680
Study 16924049 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose acitretin (25 mg/d)
Number of subjects: 0
Study 16924049 — intervention group
Group type: COMPARATOR
Intervention: High-dose acitretin (50 mg/d)
Number of subjects: 0
Study 15054734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (VE) oil solution rinse before and after radiotherapy
Number of subjects: 54
Study 15054734 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil solution rinse before and after radiotherapy
Number of subjects: 54
Study 15054734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (VE) oil solution rinse
Number of subjects: 54
Study 11532411 — intervention group
Group type: EXPERIMENTAL
Intervention: Master surgeons
Number of subjects: 20